Morgan Stanley Insight Fund Class L CPOCX

Morningstar Medalist Rating
  • NAV / 1-Day Return$18.50  /  +1.48%
  • Fund Size$1.0B
  • Adjusted Expense Ratio1.670%
  • Net Expense Ratio1.670%
  • Fee Level: DistributionAverage
  • Share Class TypeLevel Load
  • Morningstar CategoryLarge Growth
  • Equity Style Box (Funds)Mid Growth
  • Minimum Initial Investment$1,000
  • Investment StatusClosed
  • TTM Yield0.00%
  • Turnover Ratio48%

Morningstar’s Analysis CPOCX

Will CPOCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Morgan Stanley Insight L holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CPOCX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings64.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cloudflare Inc

13.20163M
Technology

Royalty Pharma PLC Class A

7.8096M
Healthcare

Tesla Inc

7.6294M
Consumer Cyclical

Affirm Holdings Inc Ordinary Shares - Class A

6.4580M
Financial Services

IonQ Inc

5.6870M
Technology

AppLovin Corp Ordinary Shares - Class A

5.0662M
Communication Services

Space Exploration Technologies Corp Class A

4.8660M
Industrials

Opendoor Technologies Inc Ordinary Shares - Class A

4.7559M
Real Estate

Aurora Innovation Inc Class A

4.7258M
Consumer Cyclical

Roivant Sciences Ltd Ordinary Shares

4.5856M
Healthcare

Sponsor Center